Representing a community of more than 28,000 practitioners and 2,100 programs and practices across the United States, ACCC has the unique ability to promote quality care for the treatment of gastrointestinal cancers. By offering the latest education, resources, and support to our partners, we can work together to improve patient outcomes and address care disparities for those diagnosed with gastrointestinal cancer.
Gastrointestinal cancers can develop anywhere in the digestive tract. The five most common types of gastrointestinal cancer are colorectal, stomach (gastric), liver, esophageal, and pancreatic. Less common are colon, gallbladder, rectal, small intestine, anal, and bile duct cancers. Treatments, which are most effective when cancer is detected early, may include surgery, chemotherapy, radiation therapy, targeted therapy, or immunotherapy.
People who smoke, heavily consume alcohol, or have unhealthy diets are at higher risk for developing gastrointestinal cancers.
Colorectal cancer represents 8.3 percent of all new cancer diagnoses in the U.S. In 2016, there were an estimated 1,324,922 people in the U.S. living with colorectal cancer.
Liver cancer, which includes hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally, responsible for more than 700,000 deaths worldwide each year.